Terragna, C; Martello, M; Martinelli, G; Durante, S; Pantani, L; Zamagni, E; Tacchetti, P; Brioli, A; Perrone, G; Zannetti, Ba; Borsi, E; Biasco, G; Baccarani, M; Cavo, M., Gene expression analysis of newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted p5, in: Suppl. 1, Chicago, «CANCER RESEARCH», 2012, 72, pp. 1873 - 1873 (atti di: AACR 2012 Annual Meeting, Chicago, 30 March - 04 April 2012) [atti di convegno-abstract]
Terragna C; Martello M; Pantani L; Patriarca F; Zamagni E; Galli M; Tacchetti P; Petrucci MT; Crippa C; Bringhen S; Brioli A; Offidani M; Perrone G; Zannetti BA; Borsi E; Testoni N; Marzocchi G; Baccarani M; Martinelli G; Cavo M., High CNA level and over-expression of genes involved in response mechanisms to genotoxic stress characterize newly diagnosed Multiple Myeloma (MM) patients carrying amplified MDM4 and/or deleted TP53, in: s1, «HAEMATOLOGICA», 2012, 97, pp. 240 - 240 (atti di: 17th Congress of the European Hematology Association, Amsterdam, The Netherlands, June 14 – 17, 2012) [atti di convegno-abstract]
Brioli A;Zamagni E;Pasquali S;Tosi P;Tacchetti P;Perrone G;Pantani L;Petrucci A;Zannetti BA;Baccarani M;Cavo M, Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition disease., «BONE MARROW TRANSPLANTATION», 2012, 47, pp. 1248 - 1249 [articolo]
Zamagni E; Petrucci A; Tosi P; Tacchetti P; Perrone G; Brioli A; Pantani L; Zannetti B; Terragna C; Baccarani M; Cavo M., Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma., «ANNALS OF HEMATOLOGY», 2012, 91, pp. 419 - 426 [articolo]
Mancini; Elisa Leo; Elena Zamagni; Paola Tacchetti; Annamaria Brioli; Lucia Pantani; Beatrice Anna Zannetti; Giovanni Martinelli; Michele Cavo, SIRT Regulates the Molecular Interaction Between c-MYC and HIF-1α in Multiple Myeloma, in: Blood, «BLOOD», 2012, 120(21), pp. 574 - 574 (atti di: 54th ASH Annual Meeting, Atlanta, GA, December 8 – 11, 2012) [atti di convegno-abstract]
Elena Zamagni;Michele Cavo, The role of imaging techniques in the management of multiple myeloma, «BRITISH JOURNAL OF HAEMATOLOGY», 2012, 159, pp. 499 - 513 [articolo]
Palumbo A.; Cavo M.; Bringhen S.; Zamagni E.; Romano A.; Patriarca F.; Rossi D.; Gentilini F.; Crippa C.; Galli M.; Nozzoli C.; Ria R.; Marasca R.; Montefusco V.; Baldini L.; Elice F.; Callea V.; Pulini S.; Carella A.M.; Zambello R.; Benevolo G.; Magarotto V.; Tacchetti P.; Pescosta N.; Cellini C.; Polloni C.; Evangelista A.; Caravita T.; Morabito F.; Offidani M.; Tosi P.; Boccadoro M., Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial., «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 986 - 993 [articolo]
PERRONE G; BORSI E; TERRAGNA C; DURANTE S; MARTELLO M; ALUIGI M; MANCINI M; ZAMAGNI E; TACCHETTI P; BRIOLI A; PANTANI L; ZANNETTI BA; MARTINELLI G; SANTUCCI MA; BACCARANI M; CAVO M, HIF 1 Alpha: A Suitable Target for Multiple Myeloma, in: Blood, «BLOOD», 2011, 118, pp. 2901 - 2901 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [atti di convegno-abstract]
TERRAGNA C; MARTELLO M; DURANTE S; PANTANI L; ZAMAGNI E; TACCHETTI P; BRIOLI A; PERRONE G; ZANNETTI BA; BORSI E; BACCARANI M; MARTINELLI G; CAVO M, High Number of Copy Number Alterations and Over-Expression of Genes Involved in the Response Mechanisms to Genotoxic Stress Both Characterize Newly Diagnosed Multiple Myeloma (MM) Patients Carrying Amplified MDM4 and/or Deleted p53, in: Blood, «BLOOD», 2011, 118, pp. 3935 - 3935 (atti di: 2011 ASH Annual Meeting, San Diego, CA, 9 – 12 December) [atti di convegno-abstract]
Zamagni E.; Brioli A.; Tacchetti P.; Zannetti B.; Pantani L.; Cavo M., Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis., «SEMINARS IN THROMBOSIS AND HEMOSTASIS», 2011, 37, pp. 209 - 219 [articolo]
Zamagni E.; Patriarca F.; Nanni C.; Zannetti B.; Englaro E.; Pezzi A.; Tacchetti P.; Buttignol S.; Perrone G.; Brioli A.; Pantani L.; Terragna C.; Carobolante F.; Baccarani M.; Fanin R.; Fanti S.; Cavo M., Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation, «BLOOD», 2011, 118, pp. 5989 - 5995 [articolo]
Cavo M; Tacchetti P; Patriarca F; Petrucci MT; Pantani L; Galli M; Di Raimondo F; Crippa C; Zamagni E; Palumbo A; Offidani M; Corradini P; Narni F; Spadano A; Pescosta N; Deliliers GL; Ledda A; Cellini C; Caravita T; Tosi P; Baccarani M, Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study., «THE LANCET», 2010, 376, pp. 2075 - 2085 [articolo]
Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A.; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M., CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS, in: Haematologica, «HAEMATOLOGICA», 2010, 95[suppl.2], pp. 214 - 214 (atti di: 15th Congress of the European Hematology Association, June 10-13, 2010, Barcelona, Spain, June 10 - 13, 2010;) [atti di convegno-abstract]
Tosi P; Zamagni E; Tacchetti P; Ceccolini M; Perrone G; Brioli A; Pallotti MC; Pantani L; Petrucci A; Baccarani M; Cavo M., Thalidomide-dexamethasone as induction therapy before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma and renal insufficiency., «BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION», 2010, 16, pp. 1115 - 1121 [articolo]
Cini M; Zamagni E; Valdré L; Palareti G; Patriarca F; Tacchetti P; Legnani C; Catalano L; Masini L; Tosi P; Gozzetti A; Cavo M, Thalidomide-dexamethasone as up-front therapy for patients with newly diagnosed multiple myeloma: thrombophilic alterations, thrombotic complications, and thromboprophylaxis with low-dose warfarin., «EUROPEAN JOURNAL OF HAEMATOLOGY», 2010, 84, pp. 484 - 492 [articolo]
